Cargando…

Prevalence of cervicovaginal human papillomavirus infection and genotype distribution in Shanghai, China

BACKGROUND: The evaluation of human papillomavirus (HPV) prevalence rate dynamics and genotype distribution could support the adoption of more targeted prevention and treatment of cervical cancer. We aimed to assess the infection status and genotype characteristics of HPV among gynecological outpati...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoxiao, Xiang, Fenfen, Dai, Junhua, Zhang, Tao, Chen, Zixi, Zhang, Mengzhe, Wu, Rong, Kang, Xiangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465878/
https://www.ncbi.nlm.nih.gov/pubmed/36096810
http://dx.doi.org/10.1186/s12985-022-01879-y
_version_ 1784787884570574848
author Li, Xiaoxiao
Xiang, Fenfen
Dai, Junhua
Zhang, Tao
Chen, Zixi
Zhang, Mengzhe
Wu, Rong
Kang, Xiangdong
author_facet Li, Xiaoxiao
Xiang, Fenfen
Dai, Junhua
Zhang, Tao
Chen, Zixi
Zhang, Mengzhe
Wu, Rong
Kang, Xiangdong
author_sort Li, Xiaoxiao
collection PubMed
description BACKGROUND: The evaluation of human papillomavirus (HPV) prevalence rate dynamics and genotype distribution could support the adoption of more targeted prevention and treatment of cervical cancer. We aimed to assess the infection status and genotype characteristics of HPV among gynecological outpatients in Shanghai, China. METHODS: Clinical specimens were collected from patients attending gynaecological department of the Putuo Hospital, Shanghai University of Traditional Chinese Medicine, between January 2015 and December 2019. The cervicovaginal infection of 17 high-risk genotypes and 10 low-risk genotypes were analyzed by Luminex-based multiple assays. RESULTS: The overall HPV infection rate was 18.81% (95% CI 18.31–19.30%) in Shanghai city, with high-risk, low-risk and mixed high- and low-risk HPV prevalence being 11.65% (95% CI 11.24–12.06%), 4.19% (95% CI 3.94–4.44%) and 2.96% (95% CI 2.74–3.17%), respectively. The five most prevalent high-risk genotypes were HPV-52 (2.95%), HPV-16 (2.34%), HPV-58 (2.07%), HPV-53 (1.67%) and HPV-39 (1.36%). The most common low-risk genotype was HPV-61 (1.52%), followed by HPV-6 (1.29%) and HPV-81 (1.19%). Moreover, the coverage of HPV genotype by nonavalent vaccine was 10.42%, and non-vaccine-covered high-risk genotype was 7.70%. The 15–24 years age group demonstrated the highest HPV prevalence (43.14%), and significant differences were observed among different age groups (P < 0.001). CONCLUSIONS: This study revealed the HPV prevalence and genotype distribution among women in Shanghai city, which could serve as guidance for HPV vaccination and preventative strategies against cervical cancer in this area. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12985-022-01879-y.
format Online
Article
Text
id pubmed-9465878
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94658782022-09-13 Prevalence of cervicovaginal human papillomavirus infection and genotype distribution in Shanghai, China Li, Xiaoxiao Xiang, Fenfen Dai, Junhua Zhang, Tao Chen, Zixi Zhang, Mengzhe Wu, Rong Kang, Xiangdong Virol J Research BACKGROUND: The evaluation of human papillomavirus (HPV) prevalence rate dynamics and genotype distribution could support the adoption of more targeted prevention and treatment of cervical cancer. We aimed to assess the infection status and genotype characteristics of HPV among gynecological outpatients in Shanghai, China. METHODS: Clinical specimens were collected from patients attending gynaecological department of the Putuo Hospital, Shanghai University of Traditional Chinese Medicine, between January 2015 and December 2019. The cervicovaginal infection of 17 high-risk genotypes and 10 low-risk genotypes were analyzed by Luminex-based multiple assays. RESULTS: The overall HPV infection rate was 18.81% (95% CI 18.31–19.30%) in Shanghai city, with high-risk, low-risk and mixed high- and low-risk HPV prevalence being 11.65% (95% CI 11.24–12.06%), 4.19% (95% CI 3.94–4.44%) and 2.96% (95% CI 2.74–3.17%), respectively. The five most prevalent high-risk genotypes were HPV-52 (2.95%), HPV-16 (2.34%), HPV-58 (2.07%), HPV-53 (1.67%) and HPV-39 (1.36%). The most common low-risk genotype was HPV-61 (1.52%), followed by HPV-6 (1.29%) and HPV-81 (1.19%). Moreover, the coverage of HPV genotype by nonavalent vaccine was 10.42%, and non-vaccine-covered high-risk genotype was 7.70%. The 15–24 years age group demonstrated the highest HPV prevalence (43.14%), and significant differences were observed among different age groups (P < 0.001). CONCLUSIONS: This study revealed the HPV prevalence and genotype distribution among women in Shanghai city, which could serve as guidance for HPV vaccination and preventative strategies against cervical cancer in this area. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12985-022-01879-y. BioMed Central 2022-09-12 /pmc/articles/PMC9465878/ /pubmed/36096810 http://dx.doi.org/10.1186/s12985-022-01879-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Xiaoxiao
Xiang, Fenfen
Dai, Junhua
Zhang, Tao
Chen, Zixi
Zhang, Mengzhe
Wu, Rong
Kang, Xiangdong
Prevalence of cervicovaginal human papillomavirus infection and genotype distribution in Shanghai, China
title Prevalence of cervicovaginal human papillomavirus infection and genotype distribution in Shanghai, China
title_full Prevalence of cervicovaginal human papillomavirus infection and genotype distribution in Shanghai, China
title_fullStr Prevalence of cervicovaginal human papillomavirus infection and genotype distribution in Shanghai, China
title_full_unstemmed Prevalence of cervicovaginal human papillomavirus infection and genotype distribution in Shanghai, China
title_short Prevalence of cervicovaginal human papillomavirus infection and genotype distribution in Shanghai, China
title_sort prevalence of cervicovaginal human papillomavirus infection and genotype distribution in shanghai, china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465878/
https://www.ncbi.nlm.nih.gov/pubmed/36096810
http://dx.doi.org/10.1186/s12985-022-01879-y
work_keys_str_mv AT lixiaoxiao prevalenceofcervicovaginalhumanpapillomavirusinfectionandgenotypedistributioninshanghaichina
AT xiangfenfen prevalenceofcervicovaginalhumanpapillomavirusinfectionandgenotypedistributioninshanghaichina
AT daijunhua prevalenceofcervicovaginalhumanpapillomavirusinfectionandgenotypedistributioninshanghaichina
AT zhangtao prevalenceofcervicovaginalhumanpapillomavirusinfectionandgenotypedistributioninshanghaichina
AT chenzixi prevalenceofcervicovaginalhumanpapillomavirusinfectionandgenotypedistributioninshanghaichina
AT zhangmengzhe prevalenceofcervicovaginalhumanpapillomavirusinfectionandgenotypedistributioninshanghaichina
AT wurong prevalenceofcervicovaginalhumanpapillomavirusinfectionandgenotypedistributioninshanghaichina
AT kangxiangdong prevalenceofcervicovaginalhumanpapillomavirusinfectionandgenotypedistributioninshanghaichina